PHAXIAM Therapeutics S.A. Interest Expense On Bonds
PHAXIAM Therapeutics S.A. reported Interest Expense On Bonds of EUR 0 for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnBonds · last filed 2023-09-26
| Period end | Interest Expense On Bonds 6 month | Interest Expense On Bonds 12 month |
|---|---|---|
| 2023-06-30 | 0.00 EUR 6-K · filed 2023-09-26 | |
| 2022-06-30 | 22.00K EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 1.57M EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 919.00K EUR 6-K · filed 2022-09-12 | |
| 2020-12-31 | 1.68M EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 0.00 EUR 6-K · filed 2021-09-20 | |
| 2019-12-31 | 0.00 EUR 20-F · filed 2022-04-27 | |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-08 |